Oncology Institute (TOIIW) Competitors $0.02 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsShort InterestTrends TOIIW vs. AVHIW, AVHIU, ACONW, AONC, DHACW, LFMDP, OTRKP, PIIIW, SHCRW, and TALKWShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include Achari Ventures Holdings Corp. I (AVHIW), Achari Ventures Holdings Corp. I (AVHIU), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Sharecare (SHCRW), and Talkspace (TALKW). These companies are all part of the "healthcare" industry. Oncology Institute vs. Achari Ventures Holdings Corp. I Achari Ventures Holdings Corp. I Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Sharecare Talkspace Oncology Institute (NASDAQ:TOIIW) and Achari Ventures Holdings Corp. I (NASDAQ:AVHIW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, community ranking, institutional ownership, media sentiment and risk. Does the media prefer TOIIW or AVHIW? In the previous week, Oncology Institute's average media sentiment score of 1.00 beat Achari Ventures Holdings Corp. I's score of 0.00 indicating that Oncology Institute is being referred to more favorably in the media. Company Overall Sentiment Oncology Institute Positive Achari Ventures Holdings Corp. I Neutral Do analysts prefer TOIIW or AVHIW? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oncology Institute 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AAchari Ventures Holdings Corp. I 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Is TOIIW or AVHIW more profitable? Company Net Margins Return on Equity Return on Assets Oncology InstituteN/A N/A N/A Achari Ventures Holdings Corp. I N/A N/A N/A Does the MarketBeat Community prefer TOIIW or AVHIW? Oncology Institute and Achari Ventures Holdings Corp. I both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformOncology InstituteN/AN/AAchari Ventures Holdings Corp. IN/AN/A Which has better earnings & valuation, TOIIW or AVHIW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncology Institute$361.07MN/AN/AN/AN/AAchari Ventures Holdings Corp. IN/AN/AN/AN/AN/A SummaryOncology Institute beats Achari Ventures Holdings Corp. I on 2 of the 2 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOIIW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOIIW vs. The Competition Export to ExcelMetricOncology InstituteMedical Care Facilities IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.22B$5.40B$8.53BDividend YieldN/A3.79%5.13%4.14%P/E RatioN/A239.11115.5615.18Price / SalesN/A66.411,484.3492.77Price / CashN/A12.9439.6634.07Price / BookN/A2.224.665.02Net IncomeN/A$51.57M$119.06M$225.46M7 Day PerformanceN/A-1.30%0.80%0.37%1 Month PerformanceN/A-0.83%5.65%3.57%1 Year PerformanceN/A15.53%36.76%29.44% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIIWOncology InstituteN/A$0.02flatN/A-89.8%$0.00$361.07M0.00660Positive NewsAVHIWAchari Ventures Holdings Corp. IN/A$0.01flatN/AN/A$0.00N/A0.003AVHIUAchari Ventures Holdings Corp. IN/A$10.00flatN/AN/A$0.00N/A0.003ACONWAclarionN/A$0.03flatN/A+10.8%$0.00$53,947.000.007Positive NewsGap DownAONCAmerican Oncology NetworkN/A$3.20+3.2%N/A-44.0%$0.00$1.34B0.001,520News CoverageDHACWDigital Health AcquisitionN/A$0.07flatN/AN/A$0.00N/A0.00N/ALFMDPLifeMDN/A$22.15-0.4%N/A+20.5%$0.00$178.28M0.00230OTRKPOntrakN/A$0.25flatN/A-19.4%$0.00$10.84M0.00250Gap DownPIIIWP3 Health PartnersN/A$0.03flatN/A-91.6%$0.00$1.40B0.00500News CoverageSHCRWSharecareN/A$0.09flatN/AN/A$0.00$403.73M0.003,280Positive NewsTALKWTalkspaceN/A$0.17-5.6%N/A+36.0%$0.00$172.54M0.00500Positive NewsGap Down Related Companies and Tools Related Companies AVHIW Alternatives AVHIU Alternatives ACONW Alternatives AONC Alternatives DHACW Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives SHCRW Alternatives TALKW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TOIIW) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
